These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15982327)
1. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma. Garcia-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M Histopathology; 2005 Jul; 47(1):82-9. PubMed ID: 15982327 [TBL] [Abstract][Full Text] [Related]
2. OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative). García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M Cancer Invest; 2008; 26(3):222-9. PubMed ID: 18317962 [TBL] [Abstract][Full Text] [Related]
3. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof]. Wang ZB; Zhao P; Liu M; Li XH Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251 [TBL] [Abstract][Full Text] [Related]
5. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365 [TBL] [Abstract][Full Text] [Related]
6. Different proliferative patterns characterize different preinvasive breast lesions. Viacava P; Naccarato AG; Bevilacqua G J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations. García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179 [TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer. Koda M; Przystupa W; Jarzabek K; Wincewicz A; Kanczuga-Koda L; Tomaszewski J; Sulkowska M; Wolczynski S; Sulkowski S Oncol Rep; 2005 Jul; 14(1):93-8. PubMed ID: 15944774 [TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718 [TBL] [Abstract][Full Text] [Related]
10. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. Zolota V; Gerokosta A; Melachrinou M; Kominea A; Aletra C; Scopa CD Anticancer Res; 1999; 19(4B):3269-74. PubMed ID: 10652623 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520 [TBL] [Abstract][Full Text] [Related]
12. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas. Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371 [TBL] [Abstract][Full Text] [Related]
13. Biological indicators of aggressiveness in T1 ductal invasive breast cancer. Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792 [TBL] [Abstract][Full Text] [Related]
14. Relationship between IL-10 and tumor markers in breast cancer patients. Llanes-Fernández L; Alvarez-Goyanes RI; Arango-Prado Mdel C; Alcocer-González JM; Mojarrieta JC; Pérez XE; López MO; Odio SF; Camacho-Rodríguez R; Guerra-Yi ME; Madrid-Marina V; Tamez-Guerra R; Rodríguez-Padilla C Breast; 2006 Aug; 15(4):482-9. PubMed ID: 16403632 [TBL] [Abstract][Full Text] [Related]
15. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781 [TBL] [Abstract][Full Text] [Related]
16. [Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer]. Wu WJ; Pan CE; Zeng J Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1001-4. PubMed ID: 16109560 [TBL] [Abstract][Full Text] [Related]
17. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas. Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965 [TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and Bcl-2 expression in human breast cancer. Elkak AE; Kirkpatrick K; Mears L; Wells C; Ghilchik M; Newbold R; Mokbel K Eur J Surg Oncol; 2002 Feb; 28(1):14-8. PubMed ID: 11869007 [TBL] [Abstract][Full Text] [Related]
19. Bax expression in untreated breast cancer: an immunocytometric study of 255 cases. Martínez-Arribas F; Martín-Garabato E; Zapardiel I; Sánchez J; Lucas AR; Tejerina A; Schneider J Anticancer Res; 2008; 28(5A):2595-8. PubMed ID: 19035283 [TBL] [Abstract][Full Text] [Related]
20. Expression of c-kit proto-oncogene product in breast tissue. Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA Breast J; 2004; 10(4):323-7. PubMed ID: 15239791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]